This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3l2a
From Proteopedia
| Line 1: | Line 1: | ||
| - | {{Seed}} | ||
| - | [[Image:3l2a.png|left|200px]] | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3l2a", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3l2a| PDB=3l2a | SCENE= }} | {{STRUCTURE_3l2a| PDB=3l2a | SCENE= }} | ||
| - | |||
===Crystal structure of Reston Ebola VP35 interferon inhibitory domain=== | ===Crystal structure of Reston Ebola VP35 interferon inhibitory domain=== | ||
| + | {{ABSTRACT_PUBMED_20399790}} | ||
| - | + | ==Function== | |
| - | + | [[http://www.uniprot.org/uniprot/VP35_EBORR VP35_EBORR]] Acts as a polymerase cofactor in the RNA polymerase transcription and replication complex. Prevents establishment of cellular antiviral state by blocking virus-induced phosphorylation and activation of interferon regulatory factor 3 (IRF3), a transcription factor critical for the induction of interferons alpha and beta. The mechanism by which this blockage occurs remains incompletely defined, a hypothesis suggests that VP35 dsRNA-binding activity prevents activation of IRF3 by sequestering dsRNA. Also inhibits the antiviral effect mediated by the interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2/PKR (By similarity). | |
| - | + | ||
| - | + | ||
| - | -- | + | |
| - | + | ||
==About this Structure== | ==About this Structure== | ||
| - | + | [[3l2a]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Reston_ebolavirus Reston ebolavirus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3L2A OCA]. | |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:020399790</ref><references group="xtra"/><references/> |
[[Category: Reston ebolavirus]] | [[Category: Reston ebolavirus]] | ||
[[Category: Amarasinghe, G K.]] | [[Category: Amarasinghe, G K.]] | ||
| Line 40: | Line 27: | ||
[[Category: Transcription]] | [[Category: Transcription]] | ||
[[Category: Virion]] | [[Category: Virion]] | ||
| - | |||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug 18 11:03:44 2010'' | ||
Revision as of 20:02, 4 April 2013
Contents |
Crystal structure of Reston Ebola VP35 interferon inhibitory domain
Template:ABSTRACT PUBMED 20399790
Function
[VP35_EBORR] Acts as a polymerase cofactor in the RNA polymerase transcription and replication complex. Prevents establishment of cellular antiviral state by blocking virus-induced phosphorylation and activation of interferon regulatory factor 3 (IRF3), a transcription factor critical for the induction of interferons alpha and beta. The mechanism by which this blockage occurs remains incompletely defined, a hypothesis suggests that VP35 dsRNA-binding activity prevents activation of IRF3 by sequestering dsRNA. Also inhibits the antiviral effect mediated by the interferon-induced, double-stranded RNA-activated protein kinase EIF2AK2/PKR (By similarity).
About this Structure
3l2a is a 1 chain structure with sequence from Reston ebolavirus. Full crystallographic information is available from OCA.
Reference
- Leung DW, Shabman RS, Farahbakhsh M, Prins KC, Borek DM, Wang T, Muhlberger E, Basler CF, Amarasinghe GK. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain. J Mol Biol. 2010 Jun 11;399(3):347-57. Epub 2010 Apr 24. PMID:20399790 doi:10.1016/j.jmb.2010.04.022
Categories: Reston ebolavirus | Amarasinghe, G K. | Basler, C F. | Borek, D M. | Farahbakhsh, M. | Leung, D W. | Prins, K C. | Host cytoplasm | Interferon antiviral evasion | Interferon antiviral system evasion | Rna binding domain | Rna binding protein | Rna replication | Rna-binding | Transcription | Virion
